Organigram reports Q1 net revenue C$30.4M vs. C$19.3M a year ago 06:08 OGI "Our record-breaking… Organigram sees Q2 revenue 'significantly higher' than 2Q21 06:10 OGI Organigram currently expects a solid Q2 Fiscal 2022 revenue which will be significantly higher than Q2 Fiscal 2021, largely due to stronger forecasted market growth and the increasing number of retail stores. The company is better able to fulfill the demand for its revitalized product portfolio with its increased production, and revenue contributions from its newly acquired Laurentian facility. Net revenue growth is expected from the company's products as evidenced by Organigram's growing national adult-use recreational retail market share from 4.4% in Q1 of Fiscal 2021 to 7.5% in Q1 of Fiscal 2022. In addition, the resumption of shipments to Canndoc in Israel is expected to generate higher sequential revenue in Fiscal 2022 as compared to Fiscal 2021. The company believes it is better equipped to fulfill demand in Fiscal 2022 with larger harvests expected as compared to Fiscal 2021. Revenues in Fiscal 2022 to date including a shipment to Canndoc that was in excess of C$3M, and purchase orders received from customers, support the company's expectation of revenue growth from Fiscal 2021 to Fiscal 2022. OGI-$ Bank of America the large cap bank stock to own for 2022, says Piper Sandler 06:08 BAC Piper Sandler analyst Jeffery Harte raised the firm's price target on Bank of America to $57 from $54 and keeps an Overweight rating on the shares. The analyst continues to believe that Bank of America is the large cap bank stock to own for 2022. Revenue tailwinds from higher interest rates seem more likely to surprise to the upside than the downside, Harte tells investors in a research note. The analyst expects the bank's capital markets-related revenue to continue surprising to the upside in 2022. Young people feel social pressure to own iPhones, WSJ reports 06:14 AAPL, GOOG, GOOGL T-Mobile upgraded to Conviction Buy from Buy at Goldman Sachs 06:18 TMUS Goldman Sachs analyst Brett Feldman added T-Mobile to the firm's Conviction List and keeps a Buy rating on the shares with an unchanged price target of $153. The analyst expects further attainment of merger integration milestones and ramping synergies in 2022. Further, he sees visibility into the timing and intensity of buybacks as well as an attractive valuation at current share levels. Insurers to cover rapid Covid-19 tests under White House plan, WSJ reports 06:22 CI, CNC, CVS, HUM, UNH, WCG, HNT, MOH, ANTM Under a Biden administration plan that aims to make it more affordable for people to screen for infections and limit the spread of the omicron variant, private health insurers will have to cover the cost of over-the-counter Covid-19 tests beginning on Saturday, The Wall Street Journal's Stephanie Armour and Brianna Abbott report. Under Biden's policy, insurers will reimburse millions of people for up to eight tests a month per covered individual, or they will be able to purchase the tests at no cost through their insurance. Publicly traded companies in the space include Anthem (ANTM), CVS Health (CVS), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG) Lucira Health Check-It COVID-19 test now available in Optum Store 07:16 LHDX Lucira Health announced that its Lucira Check-It PCR-Quality, At-Home Molecular COVID-19 Test is now available in the Optum Store. "Expanding access to Lucira's first-of-its-kind test is critical in the face of the current surge of COVID-19 cases. Our at-home molecular test delivers the lab-quality accuracy of PCR combined with the rapid, on-the-spot results of antigen tests, so you can detect early COVID-19 infection, including Omicron, before potentially putting others at risk," said Erik Engelson, President and Chief Executive Officer of Lucira Health. "The Optum Store connects consumers with high-quality, affordable health products and services to improve their overall health and care, and we're proud to offer our tests to their customers." The Lucira Check-It COVID-19 test kit has emergency authorization by FDA under EUA. Safe-T sees momentum in Asia-Pacific with 75 new clients 07:36 SFET Safe-T Group announced… Ping Identity named a Best Idea for 2022 at Stephens 07:50 PING Krispy Kreme initiated with a Buy at BofA 06:53 DNUT BofA analyst Sara Senatore initiated coverage of Krispy Kreme with a Buy rating and $23 price target. The company offers a "sweet business model" as it is able to centralize production without compromising quality, since consumer tolerance for freshness in baked goods is much wider than in most food and beverages, the analyst tells investors in a research note. Urban Outfitters reports net sales for two months ended Dec. 31 up 14.6% 08:03 URBN Urban Outfitters announced net sales for the two and eleven months ended December 31, 2021. Due to the material impact of COVID-19 on our business operations in fiscal 2021, including mandated store closures, this release includes a comparison of fiscal 2022 results to fiscal 2020. Management views the comparison of fiscal 2022 results to fiscal 2020 as the more meaningful measurement of the Company's business performance. Total Company net sales for the two months ended December 31, 2021, increased 14.6% compared to the two months ended December 31, 2019. Comparable Retail segment net sales increased 14%, driven by strong double-digit growth in digital channel sales, partially offset by high single-digit negative retail store sales primarily due to reduced store traffic. By brand, comparable Retail segment net sales increased 47% at the Free People Group, 15% at the Anthropologie Group and 3% at Urban Outfitters. Total Retail segment net sales increased 15%. Wholesale segment net sales decreased 18% primarily from reducing the Free People Group's sales to promotional wholesale customers. URBN now believes that the total Company fourth quarter gross margin could deleverage due to higher than anticipated inbound transportation costs. For the eleven months ended December 31, 2021, total Company net sales increased 14.4% compared to the eleven months ended December 31, 2019. Comparable Retail segment net sales increased 16%, driven by strong double-digit growth in digital channel sales, partially offset by low double-digit negative retail store sales due to reduced store traffic. Wholesale segment net sales decreased 22% primarily from reducing the Free People Group's sales to promotional wholesale customers. During the eleven months ended December 31, 2021, the Company opened a total of 56 new retail locations including: 29 Free People Group stores, 17 Urban Outfitters stores, 9 Anthropologie Group stores and 1 Menus & Venues restaurant; and closed 10 retail locations including: 4 Anthropologie Group stores, 2 Free People Group stores, 2 Urban Outfitters stores and 2 Menus & Venues restaurants. During the eleven months ended December 31, 2021, 1 Urban Outfitters franchisee-owned store and 1 Anthropologie Group franchisee-owned store were opened.
--> Shake Shack reports preliminary Q4 revenue $203.3M, consensus $197.92M 08:12 SHAK Ok I'm at a difficult spot with the investing as several of my big ideas are unwinding. At heart I'm a theme investor so it's very important for me to get the themes right. So yesterday high end retail got wiped out. I guess because of Omicrom. I had a theory about late arriving merch adding to huge sales in Feb but..... We'll see. They say the economy is cooking.... retail should do well....// Another large theme for me for about a year now has been testing socks I own them all and I mean I can't explain the lack of progress... If you watch carefully now one after the other are starting to turn in very large earnings... I always thought the stock market cared about earnings... maybe wrong again. -->Fluidigm sees Q4 revenue $38M-$38.3M, one est. $32.7M 08:13 FLDM Base product and service revenue of $35.1M to $35.4M, or a year-over-year growth of approximately 13%-14%. Mass Cytometry product and service revenue of $21M to $21.2M, or a year-over-year growth of approximately 8%-9%. Base Microfluidics product and service revenue of $14.1M to $14.2M or a year-over-year growth of approximately 22%. FLDM is a $3 stock!!!!
Crox has had a big couple of days and if they weren't so ugly i would by the stock. The shoe business is stabilizing everywhere. Loop Capital upgrades Steven Madden to Buy after positive news from peers 08:23 SHOO, CROX, CAL As previously reported, Loop Capital analyst Laura Champine upgraded Steven Madden (SHOO) to Buy from Hold with an unchanged $50 price target. The analyst states that she is "increasingly optimistic" near-term given this week's positive preannouncements from fellow footwear providers Caleres (CAL) and Crocs (CROX). Champine further states that the stock's 10% decline year-to-date has represented a disconnect from fundamentals, also forecasting Steven Madden to be able to pass through its cost increases.
Crocs price target raised to $190 from $180 at Loop Capital 08:29 CROX Jamf Holding helping over 60,000 active customers with Apple 08:39 JAMF, AAPL Jamf announced it is now helping more than 60,000 active customers succeed with Apple and is running on approximately 26.5 million devices worldwide. 2021 was a pivotal year for Jamf, as the company added new functionality to its Apple Enterprise Management platform to help organizations connect, manage and secure their devices. Jamf added more than 6 million devices and 13,000 customers in 2021 and is now running on approximately 26.5 million devices and serves more than 60,000 customers. These organizations include: 9 of the 10 largest companies, as ranked by Fortune 500; 22 of the 25 most valuable brands, according to Forbes; 10 of the 10 largest U.S. banks, according to Bankrate.com; 10 of the top 10 global universities, according to U.S. News & World Report; 8 of the top 10 technology companies, as ranked by Fortune; In 2021, Jamf completed its three largest contracts in its history, and ended the year with its highest gross customer revenue retention rate since its founding in 2002. DocuSign CEO buys $2.41M in common stock 08:27 DOCU In a regulatory filing, DocuSign disclosed that its CEO Daniel Springer bought 18.7K shares of common stock on January 10th in a total transaction size of $2.41M. AbbVie confirms combined 2025 Rinvoq and Skyrizi risk-adjusted sales of $15B+ 08:47 ABBV AbbVie is confirming prior revenue guidance of greater than $15B in combined Rinvoq and Skyrizi risk-adjusted sales in 2025. AbbVie now expects 2025 risk-adjusted sales of greater than $7.5B for Rinvoq and greater than $7.5B for Skyrizi. The new Rinvoq sales guidance is the result of lower expected Rinvoq sales in the U.S. following the recent label updates in approved indications, partially offset by higher anticipated sales in international markets, as well as higher anticipated global sales in Crohn's disease and ulcerative colitis following positive Phase 3 study readouts. The updated Skyrizi sales guidance is based on continued strong performance in psoriasis.
DOCU- OPENED AT $138 I MISSED IT TYPING... DocuSign, Inc. (DOCU) 141.49+5.26(+3.86%) As of 09:51AM EST.
Description Jamf Holding Corp. offers a cloud software platform for Apple infrastructure and security platform worldwide. Its products include Jamf Connect that streamlines Mac authentication and identity management; Jamf Pro, an enterprise mobility management tool that empowers IT pros and the users they support by delivering unified endpoint management for Apple devices; Jamf Now, a cloud-based MDM solution for the iPad, iPhone and Mac devices in workplace; Jamf School, a mobile device management for schools; and Jamf Protect, an endpoint security purpose built for Mac. The company also offers Jamf Nation, an online community of IT professionals focusing on Apple in the enterprise. It serves organizations, including businesses, hospitals, schools, and government agencies. The company sells its Software as a Service solutions via a subscription model, through a direct sales force, online, and indirectly via channel partners, including Apple. Jamf Holding Corp. was founded in 2002 and is headquartered in Minneapolis, Minnesota.
I got lucky I bought some SHAK yesterday just on instinct i had no idea they were reporting. Shake Shack Inc. (SHAK) NYSE - Nasdaq Real Time Price. Currency in USD 74.36+6.10(+8.94%)<------------ As of 09:51AM EST.
Sonendo, Inc. (SONX)- Perfect stock for this market- root canal 5.93+0.29(+5.14%) As of 09:51AM EST. Description Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment device for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software that integrates digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. Sonendo, Inc. was incorporated in 2006 and is headquartered in Laguna Hills, California.
LAGUNA HILLS, Calif., January 10, 2022--(BUSINESS WIRE)--Sonendo, Inc. ("Sonendo") (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced certain unaudited preliminary revenue results for the fourth quarter and full-year ended December 31, 2021. The company expects to report revenue in the range of $9.7 million to $9.9 million for the fourth quarter of 2021: Product revenue is expected to be in the range of $7.5 million to $7.7 million for the fourth quarter of 2021 which includes: GentleWave console revenue is expected to be in the range of $3.0 million to $3.1 million for the fourth quarter of 2021; and Procedure instrument revenue is expected to be approximately $3.8 million for the fourth quarter of 2021 Software revenue is expected to be approximately $2.2 million for the fourth quarter of 2021 The company expects to report total revenue in the range of $33.0 million to $33.2 million for the full year 2021, reflecting growth of 41% to 42% when compared to $23.4 million in 2020.